{"id":18068,"date":"2020-06-05T11:31:38","date_gmt":"2020-06-05T10:31:38","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=18068"},"modified":"2020-06-05T11:31:38","modified_gmt":"2020-06-05T10:31:38","slug":"ukens-ansatt-kristin-greve-isdahl-mohn","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2020\/06\/05\/ukens-ansatt-kristin-greve-isdahl-mohn\/","title":{"rendered":"[:no]Ukens ansatt – Kristin Greve Isdahl Mohn [:en]This week`s employee – Kristin Greve Isdahl Mohn [:]"},"content":{"rendered":"

[:no]\"\"<\/a>Jeg jobber som f\u00f8rsteamanuensis ved Influensa senteret, K2. I tillegg til \u00e5 undervise medisin og master studenter forsker vi p\u00e5 kollegaer og pasienter innlagt p\u00e5 sykehuset. Vi forsker p\u00e5 immunforsvaret og p\u00e5 immunologiske responser etter b\u00e5de vaksinasjon og infeksjon med influensavirus. Vi arbeider med mange ulike influensavirus og har deltatt i forskjellige kliniske studier med influensavaksiner p\u00e5 voksne, barn og helsearbeidere. M\u00e5let er \u00e5 kunne bidra til kunnskap innen immunologi for \u00e5 kunne lage bedre vaksiner i fremtiden. Det langsiktige m\u00e5let er en universell influensavaksine, en \u201cone shot fix all\u201d. Men det er nok enda langt frem. Min karriere p\u00e5 influensasenteret startet for 10 \u00e5rs siden, under svineinfluensapandemien i 2009. Da samlet vi pr\u00f8ver fra innlagte pasienter p\u00e5 infeksjonsavdelingen for \u00e5 fors\u00f8ke \u00e5 forst\u00e5 hvorfor noen blir s\u00e5 mye sykere enn andre. N\u00e5 forsker vi p\u00e5 koronaviruset, og det er den andre pandemien jeg f\u00e5r v\u00e6re med p\u00e5. Vi studerer immunologiske responser hos b\u00e5de ansatte og pasienter for \u00e5 se om vi utvikler immunitet mot det nye viruset. Det \u00e5 forske under en viral pandemi er veldig spennende, krevende og uforutsigbart. Alt m\u00e5 skje fort og det krever et stort teamarbeid. Her ved Influensa senteret har vi et fantastisk team. Vi har et utbredt internasjonalt samarbeid, og det har gitt mange spennende diskusjoner og nye perspektiver. Det \u00e5 kombinere stillingen ved K2 med klinisk arbeid som lege ved sykehuset er den perfekte kombinasjonen for meg, og jeg stortrives.<\/p>\n

 [:en]\"\"I work as an associate professor at the Influenza Center, K2. In addition to teaching medicine and master students, we research colleagues and patients admitted to the hospital. We research the immune system and on immunological responses after both vaccination and infection with influenza viruses. We work with many different influenza viruses and have participated in various clinical trials with influenza vaccines on adults, children and health workers. The goal is to be able to contribute to knowledge in immunology in order to create better vaccines in the future. The long-term goal is a universal flu vaccine, a «one shot fix all.» But it’s probably even far ahead. My career at the influenza center started 10 years ago, during the swine flu pandemic in 2009. Then we collected samples from hospitalized patients in the infection ward to try to understand why some people get so much sicker than others. Now we’re researching the coronavirus, and that’s the second pandemic I’m allowed to be a part of. We are studying immunological responses in both staff and patients to see if we develop immunity to the new virus. Researching a viral pandemic is very exciting, demanding and unpredictable. Everything has to happen fast and it requires a lot of teamwork. Here at the Influenza Center we have a fantastic team. We have a widespread international cooperation, and it has provided many exciting discussions and new perspectives. Combining the position at K2 with clinical work as a doctor at the hospital is the perfect combination for me, and I love it.[:]<\/p>\n","protected":false},"excerpt":{"rendered":"

[:no]Jeg jobber som f\u00f8rsteamanuensis ved Influensa senteret, K2. I tillegg til \u00e5 undervise medisin og master studenter forsker vi p\u00e5 kollegaer og pasienter innlagt p\u00e5 sykehuset. Vi forsker p\u00e5 immunforsvaret og p\u00e5 immunologiske responser etter b\u00e5de vaksinasjon og infeksjon med…<\/p>\n

Read more →<\/a><\/p>\n","protected":false},"author":4474,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-18068","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/18068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/4474"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=18068"}],"version-history":[{"count":3,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/18068\/revisions"}],"predecessor-version":[{"id":18075,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/18068\/revisions\/18075"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=18068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=18068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=18068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}